Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
EJNMMI Research
Published in: EJNMMI Research 1/2017

Open Access 01-12-2017 | Original research

Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization

Authors: Marco D’Arienzo, Maria Pimpinella, Marco Capogni, Vanessa De Coste, Luca Filippi, Emiliano Spezi, Nick Patterson, Francesca Mariotti, Paolo Ferrari, Paola Chiaramida, Michael Tapner, Alexander Fischer, Timo Paulus, Roberto Pani, Giuseppe Iaccarino, Marco D’Andrea, Lidia Strigari, Oreste Bagni

Published in: EJNMMI Research | Issue 1/2017

Login to get access

Abstract

Background

PET/CT has recently been shown to be a viable alternative to traditional post-infusion imaging methods providing good quality images of 90Y-laden microspheres after selective internal radiation therapy (SIRT). In the present paper, first we assessed the quantitative accuracy of 90Y-PET using an anthropomorphic phantom provided with lungs, liver, spine, and a cylindrical homemade lesion located into the hepatic compartment. Then, we explored the accuracy of different computational approaches on dose calculation, including (I) direct Monte Carlo radiation transport using Raydose, (II) Kernel convolution using Philips Stratos, (III) local deposition algorithm, (IV) Monte Carlo technique (MCNP) considering a uniform activity distribution, and (V) MIRD (Medical Internal Radiation Dose) analytical approach. Finally, calculated absorbed doses were compared with those obtained performing measurements with LiF:Mg,Cu,P TLD chips in a liquid environment.

Results

Our results indicate that despite 90Y-PET being likely to provide high-resolution images, the 90Y low branch ratio, along with other image-degrading factors, may produce non-uniform activity maps, even in the presence of uniform activity. A systematic underestimation of the recovered activity, both for the tumor insert and for the liver background, was found. This is particularly true if no partial volume correction is applied through recovery coefficients. All dose algorithms performed well, the worst case scenario providing an agreement between absorbed dose evaluations within 20%. Average absorbed doses determined with the local deposition method are in excellent agreement with those obtained using the MIRD and the kernel-convolution dose calculation approach.
Finally, absorbed dose assessed with MC codes are in good agreement with those obtained using TLD in liquid solution, thus confirming the soundness of both calculation approaches. This is especially true for Raydose, which provided an absorbed dose value within 3% of the measured dose, well within the stated uncertainties.

Conclusions

Patient-specific dosimetry is possible even in a scenario with low true coincidences and high random fraction, as in 90Y–PET imaging, granted that accurate absolute PET calibration is performed and acquisition times are sufficiently long. Despite Monte Carlo calculations seeming to outperform all dose estimation algorithms, our data provide a strong argument for encouraging the use of the local deposition algorithm for routine 90Y dosimetry based on PET/CT imaging, due to its simplicity of implementation.
Literature
1.
2.
Houle S, Yip T, Shepherd F, Rotstein L, Sniderman K, Theis E, et al. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology. 1989;172(3):857–60.CrossRefPubMed
3.
Lau W, Ho S, Leung T, Chan M, Ho R, Johnson P, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int. J. Radiat. Oncol. Biol. Phys. 1998;40(3):583–92.CrossRefPubMed
4.
Blanchard R, Morrow I, Sutherland J. Treatment of liver tumors with yttrium-90 microspheres alone. Can Assoc Radiol J. 1989;40(4):206–10.PubMed
5.
Gray B, Burton M, Kelleher D, Anderson J, Klemp P. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol. 1989;42(3):192–6.CrossRefPubMed
6.
Yan Z, Lin G, Zhao H, Dong Y. An experimental study and clinical pilot trials on Yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer. Cancer. 1993;72(11):3210–5.CrossRefPubMed
7.
8.
Lin G, Lunderquist A, Hägerstrand I, Boijsen E. Post-mortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery. 1984;96(3):517–26.PubMed
9.
Tygstrup N, Winkler K, Mellemgaard K, Andreassen M. Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery. J Clin Investig. 1962;41(3):447–54.CrossRefPubMedPubMedCentral
10.
Smits ML, Nijsen JF, van den Bosch MA, Lam MG, Vente MA, Huijbregts JE, van het Schip AD, Elschot M, Bult W, de Jong HW, Meulenhoff PC, Zonnenberg BA. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial. J Exp Clin Cancer Res. 2010;15(29):70.CrossRef
11.
Smits ML, Elschot M, van den Bosch MA, van de Maat GH, van het Schip AD, Zonnenberg BA, Seevinck PR, Verkooijen HM, Bakker CJ, de Jong HW, Lam MG, Nijsen JF. In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignancies. J Nucl Med. 2013;54(12):2093–100.CrossRefPubMed
12.
Seevinck PR, van de Maat GH, de Wit TC, Vente MA, Nijsen JF, Bakker CJ. Magnetic resonance imaging-based radiation-absorbed dose estimation of 166Ho microspheres in liver radioembolization. Int J Radiat Oncol Biol Phys. 2012 83(3):e437–e444.
13.
van de Maat GH, Seevinck PR, Elschot M, Smits ML, de Leeuw H, van Het Schip AD, Vente MA, Zonnenberg BA, de Jong HW, Lam MG, Viergever MA, van den Bosch MA, Nijsen JF, Bakker CJ. MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation. Eur Radiol. 2013;23(3):827–35.CrossRefPubMed
14.
D'Arienzo M. Emission of β+ particles via internal pair production in the 0+ – 0+ transition of 90Zr: historical background and current applications in nuclear medicine imaging. Atoms. 2013;1(1):2–12.CrossRef
15.
Lhommel R, van Elmbt L, Goffette P, Van den Eynde M, Jamar F, Pauwels S, et al. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-spheres. Eur J Nucl Med Mol Imaging. 2010;37(9):1654–62.CrossRefPubMed
16.
D’Arienzo M, Chiaramida P, Chiacchiararelli L, Coniglio A, Cianni R, Salvatori R, et al. 90Y PET-based dosimetry after selective internal radiotherapy treatments. Nucl Med Commun. 2012;33(6):633–40.CrossRefPubMed
17.
hang T, Bourgeois A, Balius A, Pasciak A. Treatment modification of Yttrium-90 radioembolization based on quantitative positron emission tomography/CT imaging. J Vasc Interv Radiol. 2013;24(3):333–7.CrossRef
18.
Elschot M, Vermolen B, Lam M, de Keizer B, van den Bosch M, de Jong H. Quantitative comparison of PET and bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PLoS One. 2013;8(2):e55742.CrossRefPubMedPubMedCentral
19.
D’Arienzo M, Filippi L, Chiaramida P, Chiacchiararelli L, Cianni R, Salvatori R, et al. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry. Ann Nucl Med. 2013;27(7):676–80.CrossRefPubMed
20.
Kao Y, Steinberg J, Tay Y, Lim G, Yan J, Townsend D, et al. Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres. EJNMMI Res. 2013;3(1):57.CrossRefPubMedPubMedCentral
21.
Bourgeois A, Chang T, Bradley Y, Acuff S, Pasciak A. Intraprocedural yttrium-90 positron emission tomography/CT for treatment optimization of Yttrium-90 Radioembolization. J Vasc Interv Radiol. 2014;25(2):271–5.CrossRefPubMed
22.
Willowson K, Forwood N, Jakoby B, Smith A, Bailey D. Quantitative 90Y image reconstruction in PET. Med Phys. 2012;39(11):7153–9.CrossRefPubMed
23.
Carlier T, Eugène T, Bodet-Milin C, Garin E, Ansquer C, Rousseau C, et al. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Res. 2013;3(1):11.CrossRefPubMedPubMedCentral
24.
van Elmbt L, Vandenberghe S, Walrand S, Pauwels S, Jamar F. Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy. Phys Med Biol. 2011;56(21):6759–77.CrossRefPubMed
25.
Bagni O, D’Arienzo M, Chiaramida P, Chiacchiararelli L, Cannas P, D’Agostini A, et al. 90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy. Nucl Med Commun. 2012;33(2):198–204.CrossRefPubMed
26.
Pasciak A, Bourgeois A, Bradley YA. Comparison of techniques for 90Y PET/CT image-based dosimetry following radioembolization with resin microspheres. Front Oncol. 2014;4
27.
Pasciak A, Bourgeois A, McKinney J, Chang T, Osborne D, Acuff S, et al. Radioembolization and the dynamic role of 90Y PET/CT. Front Oncol. 2014;4(38):1–12.
28.
The Selection, Use, Calibration, and Quality Assurance of Radionuclide Calibrators Used in Nuclear Medicine. Report of AAPM Task Group 181 (2012), American Association of Physicists in Medicine, One Physics Ellipse College Park, MD 20740–3846.
29.
Marcatili S, Pettinato C, Daniels S, Lewis G, Edwards P, Fanti S, et al. Development and validation of RAYDOSE: a Geant4-based application for molecular radiotherapy. Phys Med Biol. 2013;58(8):2491–508.CrossRefPubMed
30.
31.
Briesmeister JF, MCNP—a general Monte Carlo N-particle transport code—version 4C, Los Alamos National Laboratory report LA- 13709-M 2000.
32.
Gulec SA, Mesoloras G, Stabin M. Dosimetric techniques in 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med. 2006;47(7):1209–11.PubMed
33.
Guerra A, Laitano R, Pimpinella M. Characteristics of the absorbed dose to water standard at ENEA. Phys Med Biol. 1996;41(4):657–74.CrossRefPubMed
34.
Park M, Mahmood A, Zimmerman R, Limpa-Amara N, Makrigiorgos G, Moore S. Adsorption of metallic radionuclides on plastic phantom walls. Med Phys. 2008;35(4):1606–10.CrossRefPubMedPubMedCentral
35.
NEMA Standards publication NU 2–2007, Performance measurements of positron emission tomographs, National Electrical Manufacturers Association, 2007.
36.
Teymurazyan A, Riauka T, Jans H, Robinson D. Properties of noise in positron emission tomography images reconstructed with filtered-backprojection and row-action maximum likelihood algorithm. J Digit Imaging. 2012;26(3):447–56.CrossRefPubMedCentral
37.
Carlier T, Willowson K, Fourkal E, Bailey D, Doss M, Conti M. 90Y -PET imaging: exploring limitations and accuracy under conditions of low counts and high random fraction. Med Phys. 2015;42(7):4295–309.CrossRefPubMed
38.
Soret M, Bacharach S, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48(6):932–45.CrossRefPubMed
39.
Yoon M, Park S, Shin D, Lee S, Pyo H, Kim D, et al. A new homogeneity index based on statistical analysis of the dose-volume histogram. J Appl Clin Med Phys. 2007;8(2):9–17.CrossRefPubMed
40.
Capogni M, De Felice PA. Prototype of a portable TDCR system at ENEA. Appl Radiat Isot. 2014;93:45–51.CrossRefPubMed
41.
Fowler K, Maughan N, Laforest R, Saad N, Sharma A, Olsen J, et al. PET/MRI of hepatic 90Y microsphere deposition determines individual tumor response. Cardiovasc Intervent Radiol. 2015;39(6):855–64.CrossRefPubMedPubMedCentral
42.
van den Hoven AF, Rosenbaum CE, Elias SG, de Jong HW, Koopman M, Verkooijen HM. Insights into the dose-response relationship of Radioembolization with resin 90Y-microspheres: a prospective cohort study in patients with colorectal cancer liver metastases. J Nucl Med. 2016 Jul;57(7):1014–9.CrossRefPubMed
43.
Iaccarino G, Cacciatore A, Ungania S, Cazzato M, D'Andrea M, Strigari L. Breathing motion correction in dosimetry of liver lesion based on 90Y-PET/CT imaging. Phys Med. 2016;32:99.CrossRef
44.
Fourkal E, Veltchev I, Lin M, Koren S, Meyer J, Doss M, Yu JQ. 3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study. Med Phys. 2013;40(8):081702.CrossRefPubMed
45.
Goedicke A, Berker Y, Verburg FA, Behrendt FF, Winz O, Mottaghy FM. Study-parameter impact in quantitative 90-yttrium PET imaging for radioembolization treatment monitoring and dosimetry. IEEE Trans Med Imaging. 2013;32(3):485–92.CrossRefPubMed
46.
Attarwala AA, Molina-Duran F, Büsing KA, Schönberg SO, Bailey DL, Willowson K, Glatting G. Quantitative and qualitative assessment of yttrium-90 PET/CT imaging. PLoS One. 2014 9(11):e110401.
47.
Werner M, Brechtel K, Beyer T, Dittmann H, Pfannenberg C, Kupferschläger J. PET/CT for the assessment and quantification of 90Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases. Eur J Nucl Med Mol Imaging. 2009;37(2):407–8.CrossRefPubMed
48.
Willowson K, Tapner M, Bailey DA. Multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres. Eur J Nucl Med Mol Imaging. 2015;42(8):1202–22.CrossRefPubMedPubMedCentral
49.
Mille M, Zimmerman B, Bergeron D, Fenwick A. An investigation of the quantitative accuracy of 90Y PET and the impact on image-based dosimetry. J Nucl Med. 2015;56(suppl.3):1845.
50.
Mikell JK, Mahvash A, Siman W, Mourtada F, Kappadath SC. Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for 90Y microsphere selective internal radiation therapy. EJNMMI Phys. 2015;2(16).
51.
Grassi E, Fioroni F, Ferri V, Mezzenga E, Sarti MA, Paulus T, Lanconelli N, Filice A, Versari A, Iori M. Quantitative comparison between the commercial software STRATOS(®) by Philips and a homemade software for voxel-dosimetry in radiopeptide therapy. Phys Med. 2015 31(1):72-79.
52.
Carita Aschan A, Matti J. Toivonen. The use of TL detectors in Dosimetry of systemic radiation therapy. Acta Oncol. 1999;38(2):189–96.CrossRef
53.
Yorke E, Williams L, Demidecki A, Heidorn D, Roberson P, Wessels B. Multicellular dosimetry for beta-emitting radionuclides: autoradiography, thermoluminescent dosimetry and three-dimensional dose calculations. Med Phys. 1993;20(2):543–50.CrossRefPubMed
54.
Strandh M, Strand S, Ljungberg M, Tagesson M. Mini-TL-dosimeters for in vivo measurements. Radiother Oncol. 1995;37:S52.CrossRef
55.
Griffith MH, Yorke ED, Wessels BW, DeNardo GL, Neacy WP. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J Nucl Med. 1988;29:1795–809.PubMed
56.
Dewaraja Y, Frey E, Sgouros G, Brill A, Roberson P, Zanzonico P, et al. MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med. 2012;53(8):1310–25.CrossRefPubMedPubMedCentral
57.
Hughes G. Recent developments in low-energy electron/photon transport for MCNP6. Progress in Nuclear Sci Technol. 2014;4:454–8.CrossRef
58.
Selwyn R, Nickles R, Thomadsen B, DeWerd L, Micka JA. New internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. Appl Radiat Isot. 2007;65(3):318–27.CrossRefPubMed
59.
D’Arienzo M, Capogni M, Smyth V, Cox M, Johansson L, Solc J, et al. Metrological issues in molecular radiotherapy. EPJ Web of Conferences. 2014;77:00022.CrossRef
60.
Iatrou M, Ross S, Manjeshwar R, Stearns C. A fully 3D iterative image reconstruction algorithm incorporating data corrections. IEEE Nucl. Sci. Symp. Conf. Rec. 2004;4:2493–7.
61.
Iatrou M, Manjeshwar R, Ross S, Thielemans K, Stearns C. 3D implementation of scatter estimation in 3D PET. IEEE Nucl Sci Symp Conf Rec. 2006;4:2142–5.
Metadata
Title
Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
Authors
Marco D’Arienzo
Maria Pimpinella
Marco Capogni
Vanessa De Coste
Luca Filippi
Emiliano Spezi
Nick Patterson
Francesca Mariotti
Paolo Ferrari
Paola Chiaramida
Michael Tapner
Alexander Fischer
Timo Paulus
Roberto Pani
Giuseppe Iaccarino
Marco D’Andrea
Lidia Strigari
Oreste Bagni
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
EJNMMI Research / Issue 1/2017
Electronic ISSN: 2191-219X
DOI
https://doi.org/10.1186/s13550-017-0341-9

Other articles of this Issue 1/2017

EJNMMI Research 1/2017 Go to the issue

Original research

Initial evaluation of the Celesteion large-bore PET/CT scanner in accordance with the NEMA NU2-2012 standard and the Japanese guideline for oncology FDG PET/CT data acquisition protocol version 2.0

Original research

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC

Original research

Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model

Original research

Tracking dendritic cell migration into lymph nodes by using a novel PET probe 18F-tetrafluoroborate for sodium/iodide symporter

Short communication

Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data

Original research

Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7